2009
DOI: 10.1016/j.biomaterials.2008.10.029
|View full text |Cite
|
Sign up to set email alerts
|

BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
68
0
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 118 publications
(70 citation statements)
references
References 29 publications
0
68
0
2
Order By: Relevance
“…Recently emulsion electrospinning has emerged as another technique for prefabrication encapsulation of bioactive molecules [72][73][74][75][76][77][78][79][80]. Emulsion electrospinning involves the spinning of two immiscible solutions simultaneously.…”
Section: Emulsion Electrospinningmentioning
confidence: 99%
“…Recently emulsion electrospinning has emerged as another technique for prefabrication encapsulation of bioactive molecules [72][73][74][75][76][77][78][79][80]. Emulsion electrospinning involves the spinning of two immiscible solutions simultaneously.…”
Section: Emulsion Electrospinningmentioning
confidence: 99%
“…In the study of skeletal muscle tissue attachment and proliferation, Cooper et al [79] Chitosan based polyblend nanofibers with synthetic biopolymer polymers such as PEO, PLGA, PLLA, PVA and Hydroxyapatite (HAP) have been used as potential biomimetic scaffolds to engineer several others tissues such as bone, cartilage, tendon, etc., [48,67,76,[80][81][82][83][84]. The ability of chitosan to support cell attachment and proliferation is attributed to its chemical properties.…”
Section: Biomedical Applications For Chitosan Nanofibers Tissue Enginmentioning
confidence: 99%
“…19 BMP-2 gene transfection has been investigated for bone regeneration as an alternative to BMP-2 protein therapy. 4,5,20 So far, the main approach to gene delivery in gene therapy is viral vector systems, due to their relatively high transfection efficiency. However, the use of nonviral gene vectors has emerged as a viable alternative to viral-based gene vectors, because they overcome the limitation of viral vectors, such as immune response, oncogenicity, and difficulty in large-scale production and purification.…”
mentioning
confidence: 99%